Komic, Hana
Hallner, Alexander
Hussein, Brwa Ali
Badami, Chiara
Wöhr, Anne
Hellstrand, Kristoffer
Bernson, Elin
Thorén, Fredrik B. http://orcid.org/0000-0003-2167-7451
Funding for this research was provided by:
Assar Gabrielsson Foundation
Wilhelm and Martina Lundgren Research Foundation
Swedish Cancer Society
Swedish state via the ALF agreement
Swedish Research Council
BioCARE
Sahlgrenska Academy at the University of Gothenburg
University of Gothenburg
Article History
Received: 25 April 2023
Accepted: 21 July 2023
First Online: 19 August 2023
Declarations
:
: KH and FBT are authors of issued or pending patents protecting the use of HDC in cancer immunotherapy. The remaining authors declare no competing financial interests.